← Open Payments lookup

MICHELLE TURNER: Open Payments

NPI 1538109954 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$22,652 in 41 payments from 8 companies in 2025. Trend: 2023 $51,597 · 2024 $17,281 · 2025 $22,652

Speaker / faculty: $18,900Food & beverage: $1,447Travel & lodging: $1,305Consulting: $1,000
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP31$22,069
Bayer Healthcare Pharmaceuticals Inc.4$182
Janssen Biotech, Inc.1$132
Exelixis Inc.1$123
JAZZ PHARMACEUTICALS INC.1$84
Incyte Corporation1$26
Daiichi Sankyo Inc.1$19
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: IMFINZI, TAGRISSO, Nubeqa, RYBREVANT, CABOMETYX, ZEPZELCA, Stivarga.

Industry payments across MD — which companies pay providers there.